SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-025220
Filing Date
2020-02-05
Accepted
2020-02-05 14:11:03
Documents
2
Group Members
ANSBERT GADICKELUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV4 LLCMPM ASSET MANAGEMENT INVESTORS BV5 LLCMPM BIO 2014 NVS STRATEGIC FUND, L.P.MPM BIOVENTURES 2014 LLCMPM BIOVENTURES 2014 NVS STRATEGIC FUND GP LLCMPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KGMP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d883105dsc13ga.htm SC 13G/A 249757
2 EX-99.A d883105dex99a.htm EX-99.A 28612
  Complete submission text file 0001193125-20-025220.txt   280605
Mailing Address 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 617-425-9200
MPM BioVentures IV QP LP (Filed by) CIK: 0001358309 (see all company filings)

IRS No.: 204217788 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 16745 WEST BERNARDO DRIVE SUITE 250 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE SUITE 250 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Subject) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87858 | Film No.: 20578193
SIC: 2834 Pharmaceutical Preparations